Investment Q&A

Q: How do you rate this recently launched ETF as a way to invest short term money compared to other alternative such as high interest investment savings accounts or cashable GICs.

Q: Gotta say I’m confused,the reason Aqn dropped so much when it reported the cost to acquire Kentucky with rising interest rates was going to handcuff for future acquisitions and also had to cut their dividend,so when they announced they were not going to proceed I thought probably like others getting out of this deal would be a HUGE break and short term catalyst actually results in a further 5.2 % drop,what am I missing…thanks

Q: ECN preferred rate reset preferred shares are trading at a $3.00 discount to their $25.00 par value. That makes them over 9 per cent yield. What is the risk on these preferreds? The income is nice and it looks reasonably safe.

Q: I have some cash to deploy in various accounts. What do you suggest for income (divvy) in a cash account? to be held 3-5 years?
For capital gains to be held 2-3 years?
longterm (10-20 years) in a tax sheltered account?
Looking mostly for Canadian stocks but also a couple of US ones (but not for income)
Please take as many credits as fair. TIA

Q: Good Day

I hold some in my RRIF and was thinking of adding more as it has held up well through the last year and yields around 6% US$. what percent range do you feel is reasonable for senior loans in a RRIF as a higher risk bond proxy
Thanks for your opinion

Q: Its pretty obvious that AI is going to be a big investment thesis this year and likely for a number of years. It looks like it will be very disruptive, which will create investment opportunities. With that will come hype and promotion of low quality companies that will get propped up in the wave of AI. Like crypto, NFT's, etc etc I think AI will probably be the next craze, and a lot of money will be made and lost. But so far the only recommendations I'm reading about are mega caps like Nvidia, Apple, GOOG which can do well but they aren't going to be multibaggers. Do you have any insight into smaller companies that may benefit most from this AI boom? Looking for game changing smaller companies that have the best chance at multibagger gains? Thx

Q: Hi 5i,
I have 3 different questions- please deduct accordingly.
1.) Since March 24 KEY (+12.46%) has outperformed each of ENB (+6.21%), TRP (+8.75) and PPL (+8.06%) by fairly substantial margins. I know that's a short time frame, but can you offer an explanation for KEY's better performance, and would you expect it to continue to lead the others over the next year?
2.) GSY is at or close to its lowest level since January 2021 - do you think the relevant company, sector and economy related bad news is now priced in and expect it to recover to the $150 range over 12 - 18 months, or do you think that's a pipe dream, and why or why not?
3.) In your opinion is ET likely to recover to at least the $14.00 level (where I bought it some time ago) this calendar year - and why or why not.
Thanks!
Peter

Q: I own this company as it has sunk steadily. Hold or sell? What do you think? take my beating and invest in something else? thanks

Q: For this 10-stock all-equity TFSA portfolio (for 30-yr-old Albertan), which has 40% cash available to invest:
(a) which one or more of the 10 stocks would you suggest adding to?
(b) which new stock ideas do you feel would complement this portfolio (please suggest 5 or 6)?
NOTE: The philosophy is long-term buy & hold with minimal trading.
CURRENT HOLDINGS (weight in portfolio)
TD bank (13%)
Suncor (13%)
TC Energy (12%)
CPKC Rail (11%)
Amazon (10%)
Nutrien (10%)
Visa (9%)
Aritzia (9%)
Air Canada (8%)
Copper Mountain (6%)

Ted

Q: Peter and His Wonder Team
I thought they just reported a good quarter and yet the stock is down. What am I missing? Thanks for your assessment of this stock.

Q: The Dec financials show restricted cash held by NVEI, Please advise the reason for the restriction.
Thanks
Mike

Q: In a question today you included PPL as a potential takeover. Why did you include PPL and who do you think would be the interested party?

Q: I am following the above through Investor Suite which was a pick a while back. Morpheus appears to be the purchaser.
Is 5i is going to follow, or should this be just dropped.
Just wondering and thanks for your reply
Rick

Q: Hi There,

With the stock price down to 7.85 approx due to the bought deal, all things considered would you advise a holder to add to holdings at this time?

Thanks! Rob

Q: Hi 5i
A month ago you suggested waiting a few weeks for the turmoil in regional banks to settle down. Are we there yet? I am tempted to buy IAT (35.28) or KRE (42.65), both about 35% off their highs. thoughts?
Greg

Q: Can I get your take on Firan Technologies’ recent quarter and do you think it’s a good small cap buy? Thanks

Q: Why is there this marked difference between WTI & WCS? Is it because western Canadian oil is land locked? Is it a squeeze caused by US refineries who know there is no alternative to them as a buyer at this time? Will this difference improve when the Canadian pipeline to British Columbia is finished? The difference now is about $16.00 but at times it can be $30.00.
Thanks Dave

Q: I currently own ABBV. I am aware of the off-patent cliff for Humira. Earnings are expected to drop when they are announced at the end of this month. I'm not so sure their other two drugs - Rinvoq and Skyrizi - will be capable of picking up the slack. I had read a recent article, and it gave me the impression that Humira and its new biosimilar competitors have some active ingredient(s) that allows them to be used for patients using Rinvoq and Skyrizi (?) In other words, I'm wondering if the upside of Rinvoq and Skyrizi is limited. I think you like ABBV, but is there any concern longterm? The market doesn't appear to be pricing in the risks.

I've pared back some of my ABBV shares, and am considering selling the rest. Alternatively, how robust is Amgen's pipeline in comparison ? LLY looks historically expensive, and I already own JNJ.

Q: Hi there,

Spruce Point put out an update on their short today. What is your opinion on this? Is there any merit? Or alternatively, does this present a buying opportunity?

Thanks!

Q: Hi 5i team! Brookfield defaulted again yesterday on a dozen office buildings in Washington DC. In February it was on 2 buildings in Los Angeles. Should we be concerned or is this not material? Thanks